Test Price
2,800 AED✅ Home Collection Available
COL6A3 Gene DYT27 Genetic Test – Next-Generation Sequencing (NGS) in Dubai, UAE
Executive Summary & Core Metrics
Executive Clinical Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital‑Grade Home Collection by DHA‑licensed phlebotomists with ISO‑Certified Cold‑Chain handling for whole blood, FTA cards, or extracted DNA.
- Clinical Guidance: Complimentary telephonic post‑test clinical correlation session to interpret results with a specialist advisor.
- Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731
Licensed Molecular Lab
2800 AED
Results in 3–4 Weeks
DHA License No. 1143
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) assay scrutinizes the entire coding region of the COL6A3 gene to identify pathogenic variants linked to autosomal dominant dystonia type 27 (DYT27). Designed for UAE patients with early‑onset isolated dystonia, the test empowers neurologists and clinical geneticists with precise molecular diagnosis, enabling tailored treatment strategies and informed family counselling.
| Feature | Our COL6A3 NGS Test | Closest Alternative (Targeted Dystonia Panel) |
|---|---|---|
| Precision | Full gene sequencing via NGS with 99.9% analytical sensitivity | Limited to pre‑selected exonic hotspots; may miss novel or deep intronic variants |
| Methodology | Illumina® NovaSeq X‑grade chemistry, verified with Sanger confirmation | Multiplex ligation‑dependent probe amplification (MLPA) or small gene panels |
| Turnaround | 3–4 weeks with pre‑test genetic counselling | 4–8 weeks, often without integrated counselling |
Physician Insight & Safety Protocols
“As a clinical geneticist, I understand that discovering a potential genetic cause for dystonia can be life‑changing. This COL6A3 NGS test provides definitive molecular information that guides treatment decisions and enables informed family planning. Always integrate results with a thorough neurological evaluation and genetic counselling.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or modify any prescribed anti‑dystonic or neurological medication without the explicit instruction of your treating physician. An abrupt change may precipitate a severe dystonic storm. Always inform your doctor if you experience new symptoms while on medication.
Exclusion Criteria & Red Flags
- Not intended for acute dystonic crisis—seek emergency care immediately if severe muscle spasms impair breathing or swallowing.
- Requires patient clinical stability; this is not a stand‑alone screening tool for asymptomatic minors without prior genetic counselling and parental consent, in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019 concerning Use of ICT in Health Fields.
- Red Flag Signs: sudden loss of consciousness, autonomic instability (tachycardia, hypertension), or rapid progression of neurological deficits.
Patient FAQ & Clinical Guidance
1. What is the COL6A3 DYT27 genetic test and why is it recommended?
Direct Answer: This advanced NGS test decodes your COL6A3 gene to detect mutations causing dystonia type 27, a rare inherited movement disorder that typically appears in childhood or adolescence. It is recommended when clinical symptoms suggest a genetic form of dystonia and prior neurological evaluations are inconclusive.
2. How is the sample collected and when will I receive the results?
Direct Answer: A DHA‑licensed phlebotomist visits your home at a convenient time to collect a small blood sample or FTA card using sterile, temperature‑controlled cold‑chain transport. Results are delivered via secure online portal within 3–4 weeks, accompanied by a pre‑test genetic counselling session.
3. Does UAE health insurance cover the COL6A3 DYT27 test?
Direct Answer: Most UAE insurers cover medically necessary genetic tests. We verify your eligibility instantly via WhatsApp at +971 54 548 8731 before scheduling the appointment. Contact us to confirm your coverage.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
Your genetic data and personal health information are safeguarded under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All reports are encrypted and accessible only to authorised healthcare professionals. DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA Facility License No. 1143) and operates in compliance with ISO 9001:2015 standards (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | COL6A3 Gene (DYT27) Genetic Test – NGS |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA (≥1 µg), or FTA Card Blood Spot – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | G24.1 (Idiopathic familial torsion dystonia) |
| LOINC Code | 79371-8 (COL6A3 gene sequencing) |
| DHA Facility License & Address | DHA Facility License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians